A comparative study of the in vitro activity of meropenem and representatives of the major classes of broad-spectrum antibiotics  J. Moira Greenhalgh,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
Meropenem: laboratory and clinical data
Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent.
Defining an extended-spectrum β-lactamase
Approach to diagnosis of infective endocarditis
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
Herpes zoster in non-hospitalized children
Defining an extended-spectrum β-lactamase
In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus  A. Carricajo,
Bernard Grenier  Clinical Microbiology and Infection 
Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media  Fernando Baquero, Rafael Cantón, Fernando.
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to β-lactam antibiotics 
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide  F.G. Araujo, T.L. Slifer, J.S. Remington  Clinical.
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
J.P. Donnelly, B.E. De Pauw  Clinical Microbiology and Infection 
Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Training for the infectious diseases speciality in Norway
Cephalosporins: a pharmacological update
Laboratory diagnosis and biosafety issues of biological warfare agents
In vitro selective concentrations of cefepime and ceftazidime for AmpC β-lactamase hyperproducer Enterobacter cloacae variants  Maria-Cristina Negri,
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
C. Varela, A. Oliver, T.M. Coque, F. Baquero, R. Canton 
Elements of design: the knowledge on which we build
André Bryskier  Clinical Microbiology and Infection 
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
W.A. Craig  Clinical Microbiology and Infection 
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapy  L.
A. Bryskier  Clinical Microbiology and Infection 
Pathogenesis of catheter-related infections: lessons for new designs
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Definition of the Clinical Antibacterial Spectrum of Activity
Clinical infection services—the Leiden experience
Meropenem: laboratory and clinical data
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
Overview of cefixime use in community-acquired infections
Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France  D.
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study  R. Goering, C.-E. Nord, R.
Carratalà J.   Clinical Microbiology and Infection 
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species†   C.B. Moore,
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
G. Kahlmeter  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis  Bernard Grenier  Clinical.
Abstracts Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

A comparative study of the in vitro activity of meropenem and representatives of the major classes of broad-spectrum antibiotics  J. Moira Greenhalgh, Jeffrey R. Edwards  Clinical Microbiology and Infection  Volume 3, Pages 4S20-4S31 (January 1997) DOI: 10.1016/S1198-743X(14)65032-1 Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Chemical structures of the principal cephalosporins. Clinical Microbiology and Infection 1997 3, 4S20-4S31DOI: (10.1016/S1198-743X(14)65032-1) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Minimum inhibitory concentration (MIC) distributions of meropenem (MEM), cefpirome (CPR), cefepime (CPM) and the piperacillin/tazobactam (P+T) combination for Citrobacter freundii, Enterobacter cloacae and Pseudomonas aeruginosa. Clinical Microbiology and Infection 1997 3, 4S20-4S31DOI: (10.1016/S1198-743X(14)65032-1) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.